DASH vs VTGN · P/E 76, rev $13.72B vs rev $176.0K
DoorDash, Inc. Class A Common Stock (DASH) versus VistaGen Therapeutics Inc (VTGN) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported VTGN revenue for 2023-03-31 was $176.0K. Net income was -$12.2M. VTGN currently screens at market cap $28.1M.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. VTGN currently screens at market cap $28.1M.
Not investment advice. Open the DASH and VTGN stock pages for the full models.
Not investment advice.